GenomeWeb January 13, 2022
NEW YORK – The 40th Annual JP Morgan Healthcare Conference is being held virtually this week due to the ongoing coronavirus pandemic. Day three continued to be busy for firms operating in the diagnostics and genomic tools markets. Our coverage of presentations from day one and day two can be found here and here.
Below are brief reports on individual presentations webcast by the companies or through the JP Morgan conference portal on Wednesday.
Quantum-Si
During his presentation, Quantum-Si CEO John Stark detailed the company’s drive toward commercialization over the course of 2021, a year that saw the firm go public via a $425 million business combination transaction with a special purpose acquisition company and place its protein...
Today's Sponsors
Today's Sponsor